BREAKING: Biden Regime Prevents Shipment Of Monoclonal Antibodies

 One of Biden’s core campaign promises was that he would bring an end to the Covid-19 pandemic.  “I’m never going to raise the white flag and surrender. We’re going to beat this virus. We’re going to get it under control, I promise you.” He said during his 2020 Presidential campaign.  Tomorrow, nearly one year in to Biden’s presidency, the United States will hit a new all time high for daily covid infections.

After failing to contain the virus, Biden has effectively given up on finding a solution.  He criticized Trump for giving states autonomy to decide how to contain the virus, and now this week, said that there ‘Is no federal solution’ and that beating the virus will get solved at a ‘state level’, shortly after he boarded a helicopter to go to his vacation home in Delaware.

On Tuesday, the Florida Surgeon General claimed that the Biden administration has stopped shipments of two forms of Monoclonal antibodies because they are supposedly ineffective against the Omicron variant.  FOX News Reports

“Florida Surgeon General Joseph Ladapo accused the Biden administration of “actively preventing the effective distribution of monoclonal antibody treatments” in the United States, according to a Tuesday letter addressed to Secretary of Health and Human Services Xavier Becerra.

The Biden administration recently paused shipments of COVID-19 antibody treatments manufactured by major drug companies Regeneron and Eli Lilly amid claims that such treatments are not effective against the omicron variant of the coronavirus.

The federal government continues to supply Sotrovimab, a monoclonal antibody from the company Glaxosmithkline, which reportedly does work against omicron.”

Biden has destroyed our economy, failed to protect our borders, and failed to contain Covid-19,

BREAKING: Biden Regime Prevents Shipment Of Monoclonal Antibodies BREAKING: Biden Regime Prevents Shipment Of Monoclonal Antibodies Reviewed by Your Destination on December 30, 2021 Rating: 5

No comments